BIT:1MEDP - Euronext Milan - US58506Q1094 - Common Stock - Currency: EUR
BIT:1MEDP (7/24/2025, 7:00:00 PM)
387.7
+387.7 (+Infinity%)
The current stock price of 1MEDP.MI is 387.7 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 22.22 | 159.19B | ||
1TMO.MI | THERMO FISHER SCIENTIFIC INC | 18.97 | 136.01B | ||
DAP.DE | DANAHER CORP | 27.26 | 127.40B | ||
LO3.DE | LONZA GROUP AG-REG | 38.69 | 43.82B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 43.92 | 17.66B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 43.34 | 17.42B | ||
ILU.DE | ILLUMINA INC | 32.24 | 14.75B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 44.83 | 14.60B | ||
ERF.PA | EUROFINS SCIENTIFIC | 20.2 | 12.14B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 20.16 | 12.12B | ||
SRT.DE | SARTORIUS AG | 37.06 | 12.07B | ||
QIA.DE | QIAGEN N.V. | 22.22 | 9.58B |
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO US
Employees: 5900
Phone: 15135799911
The current stock price of 1MEDP.MI is 387.7 EUR.
The exchange symbol of MEDPACE HOLDINGS INC is 1MEDP and it is listed on the Euronext Milan exchange.
1MEDP.MI stock is listed on the Euronext Milan exchange.
MEDPACE HOLDINGS INC (1MEDP.MI) has a market capitalization of 11.14B EUR. This makes 1MEDP.MI a Large Cap stock.
MEDPACE HOLDINGS INC (1MEDP.MI) currently has 5900 employees.
The Revenue of MEDPACE HOLDINGS INC (1MEDP.MI) is expected to grow by 3.72% in the next year. Check the estimates tab for more information on the 1MEDP.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
1MEDP.MI does not pay a dividend.
MEDPACE HOLDINGS INC (1MEDP.MI) will report earnings on 2025-10-20, after the market close.
The PE ratio for MEDPACE HOLDINGS INC (1MEDP.MI) is 33.25. This is based on the reported non-GAAP earnings per share of 11.66 and the current share price of 387.7 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1MEDP.MI.
ChartMill assigns a technical rating of 1 / 10 to 1MEDP.MI.
ChartMill assigns a fundamental rating of 6 / 10 to 1MEDP.MI. 1MEDP.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months 1MEDP.MI reported a non-GAAP Earnings per Share(EPS) of 11.66. The EPS increased by 26.53% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.74% | ||
ROA | 26.61% | ||
ROE | 242.7% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 70% to 1MEDP.MI. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 2.91% and a revenue growth 3.72% for 1MEDP.MI